D. Serin

Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer

P. Fumoleau, R. Largillier, Christine Clippe et al. · European Journal of Cancer · 2003 · 307 citations

Breast Oncology, Oncology, Medicine +6

Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases

B. Cutuli, C. Cohen-Solal Le-Nir, D. Serin et al. · Critical Reviews in Oncology/Hematology · 2009 · 181 citations

Prognostic Factors, Surgical Oncology, Breast Oncology +8

Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase ii multicentre multinational study

Beat Thürlimann, R. Paridaens, D. Serin et al. · European Journal of Cancer · 1997 · 145 citations

Breast Oncology, Phase Ii, Medicine +10

Attitudes towards cancer predictive testing and transmission of information to the family.

Claire Julian‐Reynier, François Eisinger, Philippe Vennin et al. · Journal of Medical Genetics · 1996 · 128 citations · Full text

Family Medicine, Genetic Testing, Cancer Pathology +18

Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF)

I. Fogelman, Glen M. Blake, R.W. Blamey et al. · Osteoporosis International · 2003 · 107 citations

Bone Disease, Breast Oncology, Bone Health +10